Regarding management of COVID-19 in acute lymphoblastic leukemia
- PMID: 34786535
- PMCID: PMC8580212
- DOI: 10.1016/j.htct.2021.08.004
Regarding management of COVID-19 in acute lymphoblastic leukemia
Conflict of interest statement
The author declares no conflicts of interest.
Similar articles
-
COVID-19 infection in patients with acute leukemia; Istanbul experience.Am J Blood Res. 2021 Aug 15;11(4):427-437. eCollection 2021. Am J Blood Res. 2021. PMID: 34540352 Free PMC article.
-
A Child with Acute Lymphoblastic Leukemia in Institutional Isolation during the COVID Pandemic: A Multifaceted Responsibility.Indian J Palliat Care. 2020 Jun;26(Suppl 1):S170-S172. doi: 10.4103/IJPC.IJPC_167_20. Epub 2020 Jun 30. Indian J Palliat Care. 2020. PMID: 33088114 Free PMC article.
-
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.J Med Case Rep. 2021 Oct 8;15(1):504. doi: 10.1186/s13256-021-03060-5. J Med Case Rep. 2021. PMID: 34625105 Free PMC article.
-
A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia.Expert Rev Hematol. 2020 Jul;13(7):755-769. doi: 10.1080/17474086.2020.1770591. Epub 2020 Jun 1. Expert Rev Hematol. 2020. PMID: 32419532 Review.
-
Progress in the treatment of adults with acute lymphoblastic leukemia.Curr Opin Hematol. 2008 Jul;15(4):400-7. doi: 10.1097/MOH.0b013e3283034697. Curr Opin Hematol. 2008. PMID: 18536580 Review.
References
-
- McCreary E.K., Angus D.C. Efficacy of remdesivir in COVID-19. JAMA. 2020;324(11):1041–1042. - PubMed
-
- Ammad Ud Din M., Vardag A.B.S., Anwer F. Thromboprophylaxis – a neglected front in hospitalised patients with COVID-19 in Pakistan. Eur Oncol Haematol. 2020;16(1):14–15.
LinkOut - more resources
Full Text Sources